As insecticide resistance is spreading in many insect vectors of disease new agents with novel modes of action are needed. This is particularly the case for the principle malaria vector *Anopheles gambiae* where of the 4 classes of insecticides currently used i.e. organochlorines[@b1], pyrethroids[@b2], organophosphates[@b3] and carbamates[@b3], resistance has been documented for each. These insecticides act either through prolonged opening of sodium channels or inhibition of acetylcholinesterase leading to neuronal overstimulation and death of the vector.

G-protein-coupled receptors (GPCRs) comprise a large family of membrane-bound receptors found in vertebrates and invertebrates which regulate different cell signalling pathways[@b4][@b5]. In insects they regulate major biological processes such as reproduction, development, locomotion as well as feeding[@b6] and thus provide novel targets for insecticide discovery which have not yet been exploited.

One important class of messengers that primarily bind to GPCRs are biogenic amines. These can act as neurotransmitters, neuromodulators and neurohormones[@b7]. We were interested in these compounds because recently we showed in *An. gambiae* a drastic reduction in female fertility by knocking down a key enzyme responsible for tyrosine and subsequent biogenic amine synthesis (dopamine, tyramine and octopamine)[@b8]. Life traits such as oogenesis, flight behaviour and longevity are important determinants in the capacity of a mosquito vector to transmit disease. With the goal of dissecting the aminergic pathways responsible for these behaviours we focused on testing a series of biogenic amines and drugs which are known to bind dopaminergic, serotonergic and adrenergic GPCRs in humans but whose function in mosquitoes is unknown.

Biogenic amines consist of 5 members that can be found in vertebrates and invertebrates[@b9]. They are synthesised from 3 amino acids (tyrosine, tryptophan or histidine) via multiple enzymatic steps. While humans and insects both share dopamine, serotonin (5HT, 5-Hydroxytryptamine) and histamine, some amines are preferentially synthesised in vertebrates or invertebrates ([Figure 1](#f1){ref-type="fig"}). Indeed, the neurotransmitterstyramine and octopamine that are widely distributed and highly abundant in insects[@b10] are present only as traces in the mammalian nervious system compared to other biogenic amines such as adrenaline and noradrenaline[@b11]. In adrenergic signalling in insects they are regarded as the functional counterparts of noradrenaline and adrenaline in humans[@b12]. Targeting the insect specific tyramine- gated chloride channels[@b13] or octopaminergic and tyraminergic adrenergic-like receptors might represent a window for the development of novel insecticides with minimal off-target effects on non-arthropods.

The octopamine receptor agonist amitraz has been successfully used as pesticide against ticks[@b14][@b15][@b16] as well as parasitic mites[@b17], but its application to mosquitoes has not been explored. Moreover, the potential of tyramine, the metabolic precursor of octopamine, has been largely neglected. However, increases in tyramine levels either by injection of tyramine or knockdown of tyramine beta hydroxylase (TBH), the enzyme that converts tyramine to octopamine, have also been shown to inhibit insect oviposition[@b18][@b19]. Further, administration of tyramine causes opposing effects to octopamine in insect locomotion[@b20][@b21]. Similar to tyramine and octopamine, dopamine and serotonin (5-HT) are important for egg laying and locomotor behaviour[@b22][@b23][@b24][@b25]. However, in contrast to the oviposition effect seen in TBH mutants, insects with mutations in dopa decarboxylase (DDC) essential in the synthesis of serotonin and dopamine, die as embryos[@b26] highlighting the differing importance of these amines for separate aspects of insect body function. Recently amitriptyline, a serotonin antagonist has been identified as selective dopamine 2 receptor (Dop2) antagonist in the dengue and yellow fever mosquito *Aedes aegypti* causing high larval mortality[@b27]. Since fertility, locomotion and survival represent important factors that determine the ability of the mosquito to transmit disease-causing parasites, negatively affecting these life history traits through interfering with biogenic amine synthesis or function, could represent a new tool for control of vector-borne diseases. We set out to investigate this possibility through a series of experiments testing a range of different aminergic receptor agonists and antagonists for their effects on the mosquito.

Results
=======

Evolutionary relationships between selected human aminergic receptors and insect biogenic amine receptors
---------------------------------------------------------------------------------------------------------

On the assumption that the level of evolutionary relatedness of different GPCRs should positively correlate with conservation of function and ligand partner, we performed a phylogenetic analysis of the different human, fruit fly and malaria mosquito GPCRs ([Figure 2](#f2){ref-type="fig"}). As expected the aminergic GPCRs of two dipteran GPCRs were closer related to each other than to the human GPCRs and formed clusters that have been classified previously[@b28][@b29][@b30]. Our bootstrapping analysis further supported clades formed by the insect dopaminergic receptors (Dop1, Dop3), serotonergic receptors (5HT1,5,7) and α2 adrenergic-like octopamine receptors (OA3) with the respective human D1, D2, 5-HT and α2 adrenergic receptors. This was in concordance with pharmacological studies investigating GPCRs in insects which highlight potential functional similarities between human and insect GPCRs ([Table 1](#t1){ref-type="table"}). This close relationship between human and insect receptors could potentially limit the insecticidal application of molecules that target these GPCRs. Interestingly, none of the tyraminergic receptors (Tyr1-3) clustered together with the respective human adrenergic receptors, therefore molecules targeting those receptors might be more suitable to generate insect specific insecticides. Nonetheless, there are examples of clear differences in pharmacological responses of drugs against phylogenetically related receptors and even between different insect genera[@b27]. For example tick and *Aedes* mosquito D1 like receptors can be inhibited by Sch23390[@b27] while no effect is observed on the fruitfly[@b31] or honey bee Dop1 receptor[@b32]. This highlights on one hand the opportunity to potentially generate mosquito specific agents but also the need to test empirically each compound on its merit for the species of interest.

Perturbation of the adrenergic system and dopamine availability inhibits female fertility
-----------------------------------------------------------------------------------------

Our recent results showed that phenylalanine hydroxylase activity, which catalyzes the first step of phenylalanine metabolism by converting phenylalanine into tyrosine, is needed for oviposition and egg formation in *An. gambiae* mosquitoes[@b8]. Tyrosine is an essential precursor in the formation of insect neurotransmitters tyramine, octopamine and dopamine. In order to dissect the potential involvement of these biogenic amines in female mosquito fertility, we injected females with different agonists and antagonists of the adrenergic system and compounds involved in dopamine synthesis. The strongest effect on egg laying ability was observed by injection of tyramine, which resulted in complete inhibition of oviposition ([Figure 3A](#f3){ref-type="fig"}). Oviposition rate was also reduced by 16% by the tyramine-derived neurotransmitter octopamine and by 28% by the α2-adrenergic agonist clonidine, compared to the PBS-injected control. We observed that relatively few compounds (octopamine, dobutamine and dopamine) had an effect on the number of eggs laid, possibly due to the fact that injection of compounds coincided with the latter stages of oogenesis, when oocytes would be expected to be fully formed ([Figure 3B](#f3){ref-type="fig"}). However, many compounds (the α2-adrenergic agonist clonidine, α1-antagonist prazosin, the β2-agonist clenbuterol and the DDC inhibitor carbidopa) that had no effect on clutch size had a negative impact on embryo viability as measured by larval hatching rate ([Figure 3C](#f3){ref-type="fig"}). Interestingly this effect seemed to be due to either the specific activation or inactivation of each of the different adrenergic receptors and the injection of compounds with putative opposing function on α2-receptors (yohimbine, antagonist), α1 receptors (phenylephrine, agonist) and β-receptors (acebutolol, sotalol, both antagonists) had no effect. Reduction in embryo viability by carbidopa on the other hand could have been due to the fact that it targets dopa decarboxylase (DDC) which has a likely role in the formation of the embryo serosa, a protective membrane that can enclose the entire embryo[@b33].

Tyramine injection induced a preoviposition egg melanisation phenotype which can be modulated via α-adrenergic inhibition
-------------------------------------------------------------------------------------------------------------------------

Since all tyramine-injected females failed to lay eggs, we dissected their ovaries to examine egg development. Most eggs retained by females appeared to be melanised ([Figure 4A](#f4){ref-type="fig"}). This tyramine-mediated premature melanisation phenotype was very unusual, as *An. gambiae* eggs ordinarily melanise only after oviposition. It is possible that the reduced oviposition phenotype in tyramine-injected females was directly due to premature melanisation of eggs and concomitant chorion hardening that prevented their physical release from the ovary rather than a behavioural effect on oviposition stimulus. Interestingly, when we injected DOPA or dopamine, known precursors of melanin[@b34] or any other adrenergic compounds, we did not observe this premature melanisation phenotype, suggesting a tyraminergic regulatory mechanism for this process ([Figure 4B](#f4){ref-type="fig"}). To investigate this further we tried to rescue this melanisation effect in two ways: 1) by inhibition of melanin synthesis through injection of carbidopa that inhibits the dopa decarboxylase (DDC) essential for dopamine melanin and sclerotin synthesis; 2) antagonising injected tyramine activity with its antagonists prazosin or yohimbine. Fewer eggs were fully melanised in the presence of prazosin or yohimbine, suggesting a tyraminergic pathway is responsible for this effect ([Figure 4C](#f4){ref-type="fig"}). We observed only a very low proportion of females was able to lay eggs following injection with any of the above compound combinations ([Figure 4D](#f4){ref-type="fig"}) but we cannot exclude the possibility that general toxicity of these combinations contributed to low egg number and oviposition rate ([Figure 4E](#f4){ref-type="fig"}). Carbidopa did not reduce tyramine-induced pre-oviposited egg melanisation but it did inhibit melanisation post-oviposition and this was rescued by the addition of DOPA, suggesting that at that stage melanisation depends highly on dopamine availability ([Figure 4F](#f4){ref-type="fig"}).

Locomotor activity is severely disturbed by activation of the adrenergic system and inhibition of the dopaminergic and serotonergic system
------------------------------------------------------------------------------------------------------------------------------------------

Normally, following anaesthesia with a brief pulse of CO~2~, mosquitoes will require several minutes to regain posture and be able to fly again. However, in our oviposition assays we observed that upon injection of tyramine, clonidine, clenbuterol and tyramine + DOPA females required a longer recovery period post-anaesthesia of more than 2 h. In addition tyramine-injected females showed leg tremors and flight inability during that time and most of the tyramine +DOPA injected females died. This suggested that we were able to interfere in neuromuscular transmission which is required for mosquito locomotor behaviour. This is in concordance with previous studies that have shown that biogenic amines can modulate this function in other insect species[@b35][@b36]. To ascertain the relative contribution of the adrenergic and dopaminergic pathways to locomotor activity we injected female mosquitoes with a panel of agonists/antagonists that are known to interfere in these pathways in the human nervous system and measured the post-immobilisation recovery (PIR) time as a proxy for regain of locomotive function. We then classified the outcome in 3 groups ([Figure 5A](#f5){ref-type="fig"}): PIR not statistically different from PBS-injected controls (green line); significant longer PIR but \>50% recovery within 3 h (orange line); significant longer PIR but \<50% recovery within 3 h (red line). Our results showed that in general drug-mediated dopamine receptor antagonists (Sch-39166, amitriptyline), α-adrenergic (tyramine, clonidine, prazosin) and β-adrenergic (sotalol, acebutolol, dobutamine and clenbuterol) agonists and antagonists prolonged PIR significantly. The antagonist yohimbine was able to reverse the negative effect of tyramine on the locomotory behaviour. Although amitriptyline has been recently identified as dopamine receptor (Dop2) antagonist in *Ae. aegypti*, this compound has been characterised in humans mainly as inhibitor of the re-uptake of serotonin and noradrenaline[@b37]. In order to test whether the prolonged PIR seen in amitriptyline-injected females could be also caused by interference in the serotonergic system we tested other serotonergic agonists and antagonists. Indeed, compounds that are known to inhibit serotonin receptors (ketanserin) or serotonin re-uptake (citalopram) in human nervous system caused a significant increase in PIR. Citalopram and combinatory injections of amitriptyline with dopamine showed the strongest effect of all tested aminergic molecules even, in the case of citalopram, at concentrations as low as 0.25 mM (data not shown). The fact that dopamine co-injection did not rescue the effect of amitriptyline suggests that amitriptyline affects non-dopaminergic signalling in *An. gambiae* mosquitoes. Moreover, dopamine actually prolonged the PIR in coinjection with amitriptyline as well as with the alpha agonists tyramine and clonidine. Potentially these effects could be caused either by an increased imbalance between the different aminergic systems or by dopamine binding also to the respective adrenergic or serotonergic receptors thereby aggravating the effect caused by tyramine, clonidine or amitriptyline alone. The latter hypothesis is supported by studies which found that dopamine is an Oct α2R (OA3), TyR1 and TyR3 agonist in the insect nervous system[@b30][@b38]. However, it also seems plausible that a balance of these systems is essential as often different biogenic amines have opposing effects on behaviours such as egg laying and locomotion in insects[@b25][@b39].

Most of the females which were not able to resume flying within 3 h died within 24 h ([Figure 5B](#f5){ref-type="fig"}).

Together, these results showed that disruption of the β-adrenergic signalling, activation of the α2-adrenergic system, inactivation of the α1-adrenergic system, inhibition of the D1-aminergic receptor or serotonin transport/receptors can each cause defects in the female locomotor behaviour which can result further in adult death. A detailed analysis of the locomotor behaviour following injection showed that interferences in the different aminergic systems caused distinct behavioural phenotypes ([Supplementary Figure S1](#s1){ref-type="supplementary-material"}).

Amitriptyline, citalopram and tyramine are toxic for mosquito larvae
--------------------------------------------------------------------

Finally, we tested a range of the same compounds that showed adult toxicity for their effect in larval stages. The most potent of these compounds was amitriptyline, which at a concentration of 0.4 mM killed more than 90% of larvae within 24 h ([Figure 6A](#f6){ref-type="fig"}). This is comparable to its activity in the yellow fever mosquito *Ae. aegypti*[@b27]. Tyramine and citalopram were able to kill larvae but required significantly higher concentrations (40 mM) ([Figure 6B](#f6){ref-type="fig"}).

Discussion
==========

Biogenic amines are responsible for the regulation of major physiological processes. They have been extensively studied in humans and recent progress has been made to evaluate their function in insects[@b12]. We recently showed that the knockdown of a key enzyme involved in phenylalanine/tyrosine metabolism caused reduced fertility in the malaria mosquito[@b8]. Because this pathway also regulates the synthesis of 3 of the 5 insect biogenic amines we investigated how amines and drugs known to bind aminergic receptors can affect behaviours that determine reproductive capacity and survival in *An. gambiae* mosquitoes. The injection of tyramine, the insect equivalent of the human noradrenaline/adrenaline caused complete egg retention by the gravid female and premature egg melanisation. It is possible that rigidity of the chorion following melanisation could have attributed to the observed complete sterility; however, because other adrenergic compounds (clonidine and octopamine) also reduced oviposition but did not cause premature egg melanisation other factors that regulate oviposition must be important. Potentially, these could be linked to an inability to contract the oviduct muscle, which has been found to be the primary cause for sterility in *Drosophila* mutants unable to convert tyramine into octopamine due to defective tyramine beta hydroxylase[@b19][@b40][@b41][@b42]. When applied to isolated locust oviduct muscles, octopamine has been shown to cause reduced muscle contractions that are mediated via octopamine receptors[@b43][@b44]. Octopamine and clonidine might bind preferentially different adrenergic receptors compared to tyramine in mosquitoes. In fact clonidine is an α2- agonist which has been shown in some studies to bind with higher affinity to the α2- adrenergic like octopamine receptor rather than the adrenergic TyR1 receptor in insects[@b30][@b45]. Assuming these compounds bind to different adrenergic receptors, this would explain the lack of premature egg melanisation observed upon octopamine and clonidine injection. The regulation of melanin production via adrenergic compounds has been also recently observed in ticks whereby injection of the α2-adrenergic agonist guanabenz acetate caused whole body melanisation[@b18]. In our case, the melanisation induced by tyramine seemed to be limited to the eggs. Given these results, we therefore propose that oviposition is regulated via the octopaminergic and tyraminergic system, but that egg melanisation is mediated via the tyraminergic/alpha 2 adrenergic system in *An. gambiae* mosquitoes.

In line with tyraminergic regulation of egg chorion melanisation the injection of the adrenergic antagonists prazosin and yohimbine reduced the level of premelanisation of eggs. We could not confirm this for the dopamine synthesis inhibitor carbidopa, although we previously showed that its injection can cause reduced melanisation of oviposited eggs. Interestingly, injection of DOPA or dopamine in itself did not result in premature egg melanisation, indicating again that these melanin precursors are insufficient to cause melanisation alone and that regulatory mechanisms for this process must exist.

Some of the compounds, such as clonidine, prazosin, and clenbuterol did not lead to a reduction in egg numbers in contrast to the mentioned previous study in ticks[@b18], however these compounds reduced embryo viability significantly. Changes in the availability of dopamine via DOPA, dopamine or carbidopa injection also affected embryo viability. Reasons for the lack of effect in egg numbers compared to the previous study in ticks could be due to the time of injection relative to egg development. While ticks continuously produce egg batches, so that any egg laying defect caused by injection will be seen immediately, *An. gambiae* mosquitoes lay eggs in discrete batches only every 2--3 days after blood meal therefore the timing of injection may be crucial. In order to observe a maximal effect on egg laying ability and considering the short half-life of some of the compounds, we injected mosquitoes \~2--3 hours before we allowed oviposition. At that stage mosquito eggs are well developed, therefore any effect on egg synthesis by these compounds might have been diminished. Thus, potentially more of these compounds could affect the number of eggs laid if the females were injected at an earlier stage. We also found that several adrenergic, dopaminergic and serotononergic compounds affect the adult locomotor behaviour, which similar to female reproduction is obviously a determining factor for mosquito vectorial capacity. Interference in the adrenergic system by α2-agonists, α1-antagonists, β-agonists and antagonists led to reduced flight recovery. The β2-agonist clenbuterol was particularly effective, but over 40% of females recovered within 24 h. In contrast to this, at the same concentration inhibition of the dopaminergic and serotonin transport/receptor system by amitriptyline and citalopram led to a severe effect on flight recovery but also increased adult mortality to 80--100 percent within 24 h. Interestingly, in combination with dopamine, which in itself did not have an effect on locomotor activity or survival, the inhibitory effect of tyramine, clonidine and amitriptyline was accentuated. This could have been caused by dopamine binding to the respective adrenergic or serotonergic receptors or imbalances between the different aminergic systems. Dopamine has been found to bind various octopamine and tyramine receptors in insects and activation of different aminergic systems can cause opposing effects, highlighting the importance of a critical balance between these systems to maintain body function[@b25][@b39]. Combinatory insecticides which activate one system but inhibit another could be therefore more effective in killing mosquitoes. Our compound concentrations used were comparable to other studies[@b22] validating dopaminergic compounds. It remains to be seen how these correlate to concentrations that would be required in aerosol for our compounds to affect processes, such as oviposition, locomotion or respiration.

We finally tested whether adrenergic, dopaminergic and serotonergic molecules would be effective larvicides. We found that although tyramine, citalopram and amitriptyline were able to significantly reduce larval survival rapidly, the latter was the most toxic and killed larvae at a dosage that was equivalent to other pesticides[@b14]. This was in concordance with a previous finding which showed that amitriptyline can be effective at killing *Ae aegypti* larvae[@b27].

Overall we conclude that adrenergic compounds, in particular those activating the adrenergic system, are effective mosquito sterilants. Using compounds that mimic the action of tyramine could be advantageous because tyramine only occurs at low concentrations in vertebrates but at relatively high concentrations in insects, reflecting its greater usage as a neurotransmitter in insects. However, adrenergic compounds in general were less effective at limiting mosquito locomotion and larval/adult survival than dopamine receptor antagonists or serotonin transport-inhibiting reagents. We further showed that the behavioural effects can be various and distinct for these compounds.

Injection of putative agonists and antagonists of neurotransmitter signalling is an approach that has been used in the initial screening of compounds with potential insecticidal properties in a wide range of insects and arachnids[@b18][@b22][@b46]. In order to develop the aminergic compounds tested here further research investigating their pharmacological properties and their specific binding to mosquito receptors by using heterologous expression systems is needed. Nonetheless we provide a useful experimental framework to study the effect of these compounds on important life history traits as a first step in the future development of aminergic insecticides.

Methods
=======

Ethics Statement
----------------

All animal work was conducted according to UK Home Office Regulations and approved under Home Office License PPL 70/6453.

Anopheles Rearing
-----------------

The *Anopheles gambiae* G3 strain was maintained on 10% glucose solution at 28°C and 80% humidity with 12/12 h day-night light cycle.

Oviposition assay
-----------------

In order to investigate the effect of adrenergic and dopamine related compounds on ovipostion and egg maturation, females were blood-fed and then injected at a late stage of oogenesis (\~53 h post blood meal) into the thorax either with PBS solution or compound concentration of160 mM in PBS. Compounds were purchased from Sigma and resuspended in PBS prior to injection. The females were then allowed to recover from injection for 2 h before being placed into oviposition cups for egg laying in a minimum of 3 independent experiments. The likelihood of oviposition was analysed by Fisher\'s exact-test, the number of eggs and hatching rate was compared to the respective PBS control samples by Mann Whitney test and t-test of arc-sine transformed data with Welsh\'s correction respectively using the GraphPad Prism software. The proportion of females that survived was determined 24 h post-injection and analysed by t-test in 3 independent experiments (N = 10 per experiment).

Ovary dissection
----------------

In order to investigate premature egg melanisation, females were prevented from egg laying and dissected 24 h after injection. Ovaries were removed by pulling out the last 2 abdominal segments and inspected for melanisation under the dissection microscope. The arc-sine transformed proportion of dark melanised eggs was analysed between tyramine and coinjected females with tyramine with DOPA, DOPA + carbidopa, carbidopa, yohimbine and prazosin by using a Student\'s t-test.

Flight recovery assay
---------------------

Fifteen 1--2 day old adult females were anaesthetized on a CO~2~ pad and injected in their thorax with 69 nl of the compound at various concentrations (80 mM, 40 mM or 10 mM). The total time of anaesthesia was \~2--3 min. Females were then allowed to recover in paper cup. Every 15 min. the paper cap was tapped at the bottom 3 times to induce flying behaviour. The proportion of females able to fly per cup/condition was recorded for 3 h. After 24 h we recorded the number of females alive. The flight recovery responses were analysed in GraphPad Prism by non-linear regression comparing each compound vs. the respective PBS repeats (exponential one-phase association equation with plateau constraint level of less than 0.7 and comparison of curves by using extra sum of squares F- test).

Behavioural analysis
--------------------

After compound injection and anaesthesia 3 × 5 females were placed on their back (which we refer to as basal stage) into a round glass bowl radius 8 cm, height 3.5 cm which served as observation arena. The bottom of this bowl was covered with white filter paper (Whatman) to prevent females from sticking to the glass while on top we placed a transparent petri dish lid. Females were allowed to acclimate for 15 min. before the bottom of the bowl was tapped 3 times and their behavioural response was video recorded for 1 min. This procedure was repeated after 30 min, 45 min, 1 h and 3 h. We then analyzed the video by tracking each individual female for the entire minute and scoring the following behaviours as mutually exclusive: 1) the stationary behaviours: on back, upright (no movement) and 2) other behaviours: leg and wing movement without taxis, walking, flying, jumping, grooming, falling over and seizures. Jumping refers to a sudden leap (max. 1 sec) by the mosquito without movement of wings. When mosquitoes rubbed their legs we considered this behaviour as grooming. Falling over described a situation in which the female loses balance and overturns. Females with seizures showed convulsions with rapid uncontrolled movements of the body. A behavioural profile corresponding to the injected compound was determined by measuring how much time injected females spent in each behaviour, adding up to a total of 100%. We analysed the mean behavioural profile of 15 females per compound by Student\'s t-test. All observations were performed at the mosquito day cycle and the multiple treatment groups were performed in a randomized order.

Larval survival assay
---------------------

10 L2--L3 larvae were placed per well of a 24well Nunc plate (VWR). Amitriptyline, tyramine and citalopram were dissolved in PBS and added at a final concentration of 40 mM, 1 mM, 400 µM or 100 µM to the well (total volume: 2 ml). 5 repeats were performed for the all but the 40 mM concentration. Larval movement was recorded daily by gentle tapping on the Nunc plate. Non-moving larvae were recorded as dead when touched with a pipette.
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![Biosynthesis pathway of biogenic amines in invertebrates and vertebrates.\
DBH- dopamine β- hydroxylase, DDC- Dopa decarboxylase, PNMT- phenyl ethanolamine-N-methyltransferase, PO- phenoloxidase, TDC- tyrosine decarboxylase, TBH- tyramine beta hydroxylase, TPH- tryptophan hydroxylase. The green and blue squares mark the metabolic reactions specific for either invertebrates or vertebrates respectively. The dotted arrow represents a salvage pathway which might exist[@b12]. Its physiological relevance is unknown.](srep05526-f1){#f1}

![Phylogenetic analysis of selected human, fly and mosquito biogenic amine receptors.\
Protein sequences of each receptor ("R") were first aligned in Muscle[@b47] and then a Maximum-Likelihood tree was constructed in MEGA 6 using 1000-fold bootstrap re-sampling. All insect receptors are shown in green, while the human receptors are highlighted in blue. The numbers at the nodes of the branches represent the level of bootstrap support for each branch. The *D.melanogaster* FMRF amide receptor (DmFR, AAF47700.1) was used as outgroup. The accession numbers for each receptor are listed in [Supplementary Table S1](#s1){ref-type="supplementary-material"}.](srep05526-f2){#f2}

![Female fertility after injection of adrenergic and dopamine-related compounds.\
(a) Mean ± standard error of the mean (SEM) proportion of females that oviposited (N = 10 per experiment). The Fisher\'s exact Test was used to determine the Likelihood of oviposition of the PBS control vs. compound from a minimum of 3 experiments, red error bars indicate p\<0.05. (b) Mean ± SEM number of eggs per ovipositing female (Mann Whitney test, in red p\<0.05), N/A not applicable. (c) Mean ± SEM hatching rate of eggs laid per female (Student\'s t-test, in red p\<0.05).](srep05526-f3){#f3}

![Premature egg melanisation phenotype mediated by tyramine.\
(a) Ovary dissection of PBS (control) and tyramine-injected females 3 days post-bloodmeal. (b) Representative examples of eggs dissected from female ovaries \~24 h after aminergic compound injection. (c) Mean ± SEM melanisation ratio of egg batches dissected from ovaries of 31--35 injected females from 3 repeats. (d) Mean ± SEM number of eggs laid by females following injection of tyramine alone or in combination with other compounds (N = 10 per experiment, minimum of 3 experiments, Student\'s t-test, in red p\<0.05). (e) Proportion of females that survived 24 h post-injection with compounds (N = 10, minimum of 3 repeats, Student\'s t-test, in red p\< 0.05). (f) Mean ± SEM melanisation ratio of egg batches laid by injected females (N = 10 per experiment, 3 experiments, Student\'s t-test, in red p\< 0.05).](srep05526-f4){#f4}

![Effect of aminergic compounds on flying ability and survival.\
(a) Flying ability of females in response to injection of aminergic compounds at various concentrations after CO~2~ knockdown (N = 15). Effects were grouped in 3 classes: in green - no effect; in orange- significant effect, but 50% of females recovered within 3 h; in red- significant effect, recovery lower than 50% within 3 h. The experiment was performed in a minimum of 3 independent repeats. Curves were analysed by non-linear regression (one phase association, constraint: plateau level lower than 0.7, extra sum of squares F- test, p\<0.05 is significant). ND-not determined (b) Survival rate of 15 females injected with compounds that caused significant effects on flight recovery (N = 15 per experiment, 3 repeats, Student\'s t-test, p\<0.05 is significant).](srep05526-f5){#f5}

![Larval survival in the presence of dissolved tyramine, citalopram and amitriptyline.\
(a) In 5 repeats the survival of 10 larvae per treatment (final concentration: 40 mM, 1 mM, 400 uM, 100 uM) was monitored and compared to the PBS control over a period of 24 h. (Student\'s t-test, p\<0.05 is significant). (b) Larval survival rate (N = 10) within 6 h after rearing in 40 mM compound solution.](srep05526-f6){#f6}

###### Adrenergic, dopaminergic and serotonergic action of compounds applied in humans and insects

  compound                                                                                       function in humans                                                                                          function in insects                                                               Reference
  --------------------------------------------- -------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------- ------------------------------------------------------
  Tyrosine                                                                   Precursor of DOPA, dopamine, adrenaline and noradrenaline                                                      Precursor of DOPA, dopamine, tyramine and octopamine                                               \[[@b48]\]
  L-DOPA                                                                        D(1-4) dopamine receptor agonist, dopamine precursor                                                                Dopamine and DOPA melanin precursor,                                                \[[@b48],[@b49],[@b50]\]
  Dopamine                                                D(1-4) dopamine receptor agonist, dopamine transport inducer, dopamine beta hydroxylase ligand,             dopamine melanin precursor, Dop1-3 receptor agonist, Oct α2R (OA3) agonist, TyR1 and TyR3 agonist      \[[@b27],[@b29],[@b30],[@b38],[@b51],[@b52]\]
  Carbidopa                                                                      Aromatic amino acid decarboxylase (AADC) inhibitor                                                                             DDC inhibitor                                                              \[[@b53],[@b54]\]
  Tyramine                                               Trace amine associated receptor (TAAR) agonist, β-adrenergic receptor 1 and 2 (ADBR1,2) antagonist                             Oct α2R (OA3) agonist, TyR1-3 agonist, Dop3 (D2 like) agonist                     \[[@b29],[@b30],[@b38],[@b45],[@b55],[@b56],[@b57]\]
  Octopamine                                                                      TAAR agonist, ADRB2-antagonist, ADRB1,3-agonist                                                  Oct α2R (OA3) agonist, TyR 1 agonist, OctβR (OA2) agonist, TyR3 agonist                   \[[@b29],[@b30],[@b38],[@b57],[@b58],[@b59]\]
  Clonidine                                                                                    α2 adrenergic agonist                                                                  TyR \> OctR agonist, Oct α2R (OA3) agonist, OctR 1 (OA1) agonist                                  \[[@b30],[@b60],[@b61]\]
  Yohimbine                                                            α2, 5-HT(1B), 5-HT(1D), and D(2) receptor antagonist, 5HT (1A) agonist                               TyR 1 antagonist, 5-HT1,2,7 antagonist, OctR1 (OA1) antagonist, TyR\>OctR antagonist          \[[@b28],[@b30],[@b45],[@b61],[@b62],[@b63],[@b64]\]
  Prazosin                                                                                         α1 antagonist                                                                       TyR1 (Oct/Tyr) antagonist, 5-HT1,7 antagonist, OctR antagonist                               \[[@b58],[@b61],[@b65],[@b66]\]
  Phenylephrine                                                                                      α1 agonist                                                                                          TyR agonist, Oct R agonist                                                        \[[@b67],[@b68]\]
  Clenbuterol                                                                                        β2 agonist                                                                                                      ND                                                                        \[[@b69]\]
  Dobutamine                                                                                     β1 and α1 agonist                                                                                                   ND                                                                        \[[@b70]\]
  Acebutolol                                                                                       β1 antagonist                                                                                                     ND                                                                        \[[@b71]\]
  Sotalol                                                                                     Non-selective β- blocker                                                                                               ND                                                                        \[[@b72]\]
  Amitriptyline                                  Noradrenaline and serotonin transport (SERT) inhibitor, 5HT-2A receptor antagonist, TrkA and TrkB receptor agonist                                            Dop2 antagonist                                               \[[@b27],[@b73],[@b74],[@b75],[@b76],[@b77]\]
  Sch-39166 (Ecopipam)                                                                         D1 receptor antagonist                                                                                                ND                                                                        \[[@b78]\]
  SKF-38393                                                                                     D1 receptor agonist                                                                                  Dopamine 1 receptor (Dop1) agonist                                                    \[[@b27],[@b79]\]
  Domperidone                                                                                D2,D3 receptor antagonist                                                                                    Dop3 (D2 like) antagonist                                                        \[[@b80],[@b81]\]
  Bromocriptine                                   D2,D3, 5-HT receptor agonist, α2-adrenergic, D1 receptor antagonist, inactivates dopamine D4 and 5-HT7 receptors                                         Dop3 (D2 like) agonist                                                       \[[@b55],[@b82],[@b83]\]
  Serotonin (5HT)                                                                                   5-HT agonist                                                                                  5HT1,2,7 agonist, Dop3 (D2 like) agonist                                          \[[@b55],[@b61],[@b63],[@b66]\]
  5-Methyl-N,N-dimethyltryptamine (5-MeO-DMT)                                                       5-HT agonist                                                                                                5-HT2 agonist                                                              \[[@b63],[@b84]\]
  Ketanserin                                                                                      5-HT antagonist                                                                                             5-HT2 antagonist                                                             \[[@b63],[@b85]\]
  Citalopram                                                                                       SERT inhibitor                                                                                                    ND                                                                        \[[@b86]\]

ND-not determined.
